Renal biomarkers are substances measured in biological samples to assess kidney function and detect kidney diseases. They help diagnose, monitor, and predict outcomes of kidney conditions. Common biomarkers include creatinine and blood urea nitrogen (BUN) for evaluating kidney filtration, cystatin C for a more accurate estimate of glomerular filtration rate (GFR), and albumin in urine indicating kidney damage. Early markers of acute kidney injury (AKI) like neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) are also used. These biomarkers provide crucial insights into kidney health and aid in the effective management of kidney diseases.
Renal Biomarkers Market Overview
The global renal biomarkers market is expected to grow significantly with a notable CAGR during the forecast period (2024-2031).
Renal biomarkers are crucial for diagnosing and identifying patients at risk of developing kidney diseases by measuring their levels in blood or urine. These biomarkers are typically released during acute or chronic kidney injuries, which involve the rapid or gradual loss of kidney function, leading to serious clinical consequences.
Request for free sample:https://www.datamintelligence.com/download-sample/renal-biomarkers-market
Renal Biomarkers Market Growth Trends
Chronic kidney disease (CKD) is a major risk factor for cardiovascular disease, diabetes, hypertension, glomerulonephritis, and aging. World Kidney Day, a global awareness campaign, estimates that 10% of the global population is affected by CKD. According to the Centers for Disease Control and Prevention (CDC), over 26 million Americans are affected by CKD. If untreated, CKD can progress to end-stage renal disease (ESRD). The National Kidney Foundation estimated that in 2015, about 468,000 ESRD patients in the U.S. were on dialysis.
Get your customized report @https://www.datamintelligence.com/customize/renal-biomarkers-market
Renal Biomarkers Market is segmented
By Assay Platform Type: Chemiluminescent Enzyme Immunoassay (CLIA), Colorimetric Assay, Enzymatic Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Liquid Chromatography-Mass Spectrometry (LS-MS
By Type: Functional Biomarker, Up-Regulated Proteins, Others
By End Users: Diagnostic Labs, Hospitals, Outpatient Clinics, Research Centre’s
By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa
Renal Biomarkers Companies
- Abbott Laboratories
- BioPorto Diagnostics AS
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Pacific Biomarkers
- BioMérieux
- Beckman Coulter (Danaher Corporation)
- Randox Laboratories Ltd
- Siemens Healthineers
- Alere Inc.
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Contact Person: Sai. K
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across.
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek